The safety and efficacy of low-dose oral contraceptives

References

• Department of Health, Medical Research Council, OrcMacro. South Africa demographic and health survey 2003. Pretoria: Department of Health; 2007 [homepage on the Internet]. Available from: http://www.doh.gov.za/docs/misc/sadhs-f.html
   Google Scholar
• Wells BG, Dipiro JT, Schwinghammer TL, Hamilton CW, editors. Pharmacotherapy handbook. 5th ed. New York: McGraw-Hill, 2002; p. 274–292.
   Google Scholar
• Theron F, Grobler F. Kontrasepsie: teorie en praktyk. 3rd ed. Pretoria: Van Schaik, 2000; p. 1–16.
   Google Scholar
• Beers MH, Berkow R, editors. The Merck manual of diagnosis and therapy. 17thed. USA: Merck Research Laboratories, 1999; p. 1925–1933 and p. 1995–2002.
   Google Scholar
• Zieman M. Overview of contraception. UptoDate [homepage on the Internet]. c2009. Available from: http://www.utdol.com
   Google Scholar
• Farrer F. Contraception: a review. S Afr Pharm J. 2009; 76(6): 18–22.
   Google Scholar
• Godeau E, Gabhainn SN, Vignes C, et al. Contraceptive use by 15-year-old students at their last sexual intercourse. Arch Pediatr Adolesc Med. 2008; 162(1)66–73.
   Google Scholar
• Gibbon CJ, editor. South African medicines formulary. 8th ed. Cape Town: Health and Medical Publishing Group, 2008; p. 230–237, 326 and 425.
   Google Scholar
• Thorneycroft IH, Cariati SL. Ultra-low-dose oral contraceptives: are they right for your patient? Medscape [homepage on the Internet]. c2009. Available from: http://www.medscape.com/viewarticle/408944_print
   Google Scholar
• Rosenberg L, Palmer JR, Rao RS, Shapiro S. Low-dose oral contraceptive use and the risk of myocardial infarction. Arch Intern Med. 2001; 161: 1065–1070.
   PubMed Web of Science ®Google Scholar
• Van Vlijmen EFW, Brouwer J-LP, Veeger NJGM, et al. Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects. Arch Intern Med. 2007; 167: 282–289.
   PubMed Web of Science ®Google Scholar
• Martin KA, Douglas PS. Risk and side effects associated with estrogen-progestin contraceptives. UptoDate [homepage on the Internet]. c2009. Available from: http://www.utdol.com
   Google Scholar
• Masimasi N, Sivanandy MS, Thacker HL. Update on hormonal contraception. Cleve Clin J Med. 2007; 74(3): 186–198.
   PubMed Web of Science ®Google Scholar
• Aitken RJ, Baker MA, Doncel GF, et al. As the world grows: contraception in the 21st century. J Clin Invest. 2008; 118(4): 1330–1343.
   PubMed Web of Science ®Google Scholar
• Martin KA, Barbieri RL. Overview of the use of estrogen-progestin contraceptives. UptoDate [homepage on the Internet]. c2009. Available from: http://www.utdol.com
   Google Scholar
• Katzung BG, editor. Basic and clinical pharmacology. New York: Lange Medical Books/McGraw-Hill, 2004; p. 672–679.
   Google Scholar
• Lalley JJ. Oral contraceptives overview [homepage on the Internet]. c2009. Available from: http://www.med.umich.edu/obgyn/resdir/contraception/OralContLalley.htm
   Google Scholar
• Kaunitz AM. Progestin-only pills (minipills) for contraception. UptoDate [homepage on the Internet]. c2009. Available from: available from URL http://www.utdol.com
   Google Scholar
• YAZ®: a low-dose oral contraceptive with drospirenone and a 24/4 regimen. S Afr Pharm J. 2009; 76(7): 38.
   Google Scholar
• Audet M-C, Moreau M, Koltun WD, et al. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive. JAMA. 2001; 285(18): 2347–2354.
   PubMed Web of Science ®Google Scholar
• Legro RS, Pauli JG, Kunselman AR, et al. Effects of continuous versus cyclical oral contraception: a randomized controlled trail. J Clin Endocrinol Metab. 2008; 93(2): 420–429.
   PubMed Web of Science ®Google Scholar
• Grobler A. Continuous oral contraceptive use. Medifile. 2007; 21(10): 51–56.
   Google Scholar
• World Health Organization. Medical eligibility criteria for contraceptive use. 4th ed. Geneva: World Health Organization, 2009; p. 1–42 [homepage on the Internet]. Available from: http://whqlibdoc.who.int/publications/2009/9789241563888_eng.pdf
   Google Scholar
• Pfrunder A, Schiesser M, Gerber S, et al. Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial. Br J Clin Pharmacol. 2003; 56(6): 683–690.
   PubMed Web of Science ®Google Scholar
• Olutunmbi Y, Paley K, English JC. Adolescent female acne: etiology and management. J Pediatr Adolesc Gynecol. 2008; 21: 171–176.
   PubMed Web of Science ®Google Scholar
• Tan JKL. New developments in hormonal therapy for acne. Skin Therapy Lett. 2007; 12(7): 1–3.
   PubMedGoogle Scholar
• Friedenson B. A current perspective on genetic testing for breast and ovarian cancer: the oral contraceptive decision. Medscape [homepage on the Internet]. c2009. Available from: http://www.medscape.com/viewarticle/408191_print
   Google Scholar
• Modan B, Hartge P, Hirsh-Yechezkel G, et al. Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. N Eng J Med. 2001; 345(4): 235–240.
   PubMed Web of Science ®Google Scholar
• Dunn N, Thorogood M, Faragher B, et al. Oral contraceptives and myocardial infarction: results of the MICA case-control study. BMJ. 1999; 318: 1579–1584.
   PubMed Web of Science ®Google Scholar
• Tanis BC, Van Den Bosch MAAJ, Kemmeren JM, et al. Oral contraceptives and the risk of myocardial infarction. N Eng J Med. 2001; 345(25): 1787–1793.
   PubMed Web of Science ®Google Scholar
• Petitti DB, Sidney S, Bernstein A, et al. Stroke in users of low-dose oral contraceptives. N Eng J Med. 1996; 335(1): 8–15.
   PubMed Web of Science ®Google Scholar
• Chan W-S, Ray J, Wai EK, Ginsburg S, et al. Risk of stroke in women exposed to low-dose oral contraceptives. Arch Intern Med. 2004; 164: 741–747.
   PubMed Web of Science ®Google Scholar
• Gillum LA, Mamidipudi SK, Johnston SC. Ischemic stroke risk with oral contraceptives: a meta-analysis. JAMA. 2000; 284(1): 72–78.
   PubMed Web of Science ®Google Scholar
• Gomes MP Deitcher SR. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy. Arch Intern Med. 2004; 164(18): 1965–1976.
   PubMed Web of Science ®Google Scholar
• Grabrick DM, Hartmann LC, Cerhan JR, et al. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. JAMA. 2000; 284(14): 1791–1798.
   PubMed Web of Science ®Google Scholar
• Marchbanks PA, McDonald JA, Wilson HG, et al. Oral contraceptives and the risk of breast cancer. N Eng J Med. 2002; 346(26): 2025–2032.
   PubMed Web of Science ®Google Scholar